DualityBio signs global collaboration and license deal with Genentech for ADCs
DualityBio entered a global collaboration and license agreement with Genentech to develop next-generation ADCs using DualityBio’s DUPAC novel-payload platform.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.